Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Nuclear Medicine

  Free Subscription


Articles published in Neurology

Retrieve available abstracts of 86 articles:
HTML format



Single Articles


    October 2021
  1. DELVA A, Michiels L, Koole M, Van Laere K, et al
    Synaptic Damage and Its Clinical Correlates in People With Early Huntington Disease: A PET Study.
    Neurology. 2021 Oct 18. pii: WNL.0000000000012969.
    PubMed     Abstract available


  2. MCCABE JJ, Camps-Renom P, Giannotti N, McNulty JP, et al
    Carotid Plaque Inflammation Imaged by PET and Prediction of Recurrent Stroke at 5 Years.
    Neurology. 2021 Oct 5. pii: WNL.0000000000012909.
    PubMed     Abstract available


    September 2021
  3. MILA-ALOMA M, Brinkmalm A, Ashton NJ, Kvartsberg H, et al
    CSF Synaptic Biomarkers in the Preclinical Stage of Alzheimer Disease and Their Association With MRI and PET: A Cross-sectional Study.
    Neurology. 2021 Sep 23. pii: WNL.0000000000012853.
    PubMed     Abstract available


  4. SCHINDLER S, Li Y, Buckles VD, Gordon BA, et al
    Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PET.
    Neurology. 2021 Sep 9. pii: WNL.0000000000012775.
    PubMed     Abstract available


  5. MCCARTER S, Lesnick TG, Lowe V, Mielke MM, et al
    Cerebral Amyloid Angiopathy Pathology and Its Association With Amyloid-beta PET Signal.
    Neurology. 2021 Sep 9. pii: WNL.0000000000012770.
    PubMed     Abstract available


    August 2021
  6. BEUCLER N
    Reader Response: Scan-Negative Cauda Equina Syndrome: A Prospective Cohort Study.
    Neurology. 2021;97:457.
    PubMed    


  7. HOERITZAUER I, Carson A, Statham P, Demetriades A, et al
    Author Response: Scan-Negative Cauda Equina Syndrome: A Prospective Cohort Study.
    Neurology. 2021;97:456-457.
    PubMed    


  8. AMELOT A, Planty-Bonjour A, Terrier LM
    Reader Response: Scan-Negative Cauda Equina Syndrome: A Prospective Cohort Study.
    Neurology. 2021;97:455-456.
    PubMed    


  9. FRISON E, Proust-Lima C, Mangin JF, Habert MO, et al
    Diabetes Mellitus and Cognition: Pathway Analysis in the MEMENTO Cohort.
    Neurology. 2021;97:e836-e848.
    PubMed     Abstract available


    July 2021

  10. [(11)C]PK11195-PET Brain Imaging of the Mitochondrial Translocator Protein in Mitochondrial Disease.
    Neurology. 2021 Jul 27. pii: WNL.0000000000012559.
    PubMed    


  11. WOLTERS EE, Papma JM, Verfaillie SCJ, Visser D, et al
    [18F]Flortaucipir PET Across Various MAPT Mutations in Presymptomatic and Symptomatic Carriers.
    Neurology. 2021 Jul 1. pii: WNL.0000000000012448.
    PubMed     Abstract available


    June 2021
  12. TODISCO M, Zangaglia R, Minafra B, Pisano P, et al
    Clinical Outcome and Striatal Dopaminergic Function After Shunt Surgery in Patients With Idiopathic Normal Pressure Hydrocephalus.
    Neurology. 2021;96:e2861-e2873.
    PubMed     Abstract available


  13. BUCIUC M, Duffy JR, Machulda MM, Graff-Radford J, et al
    Clinical, Imaging, and Pathologic Characteristics of Patients With Right Versus Left Hemisphere-Predominant Logopenic Progressive Aphasia.
    Neurology. 2021 Jun 4. pii: WNL.0000000000012322.
    PubMed     Abstract available


    May 2021
  14. SHIN JH, Lee JY, Kim YK, Yoon EJ, et al
    Parkinson Disease-Related Brain Metabolic Patterns and Neurodegeneration in Isolated REM Sleep Behavior Disorder.
    Neurology. 2021 May 19. pii: WNL.0000000000012228.
    PubMed     Abstract available


  15. SARACINO D, Ferrieux S, Nogues-Lassiaille M, Houot M, et al
    Primary Progressive Aphasia Associated With GRN Mutations: New Insights Into the Non-amyloid Logopenic Variant.
    Neurology. 2021 May 12. pii: WNL.0000000000012174.
    PubMed     Abstract available


  16. MAYBLYUM DV, Becker JA, Jacobs HIL, Buckley RF, et al
    Comparing PET and MRI Biomarkers Predicting Cognitive Decline in Preclinical Alzheimer Disease.
    Neurology. 2021 May 5. pii: WNL.0000000000012108.
    PubMed     Abstract available


    April 2021
  17. BOERWINKLE AH, Wisch JK, Chen CD, Gordon BA, et al
    Temporal Correlation of CSF and Neuroimaging in the Amyloid-Tau-Neurodegeneration Model of Alzheimer Disease.
    Neurology. 2021 Apr 30. pii: WNL.0000000000012123.
    PubMed     Abstract available


  18. RIOU A, Houvenaghel JF, Dondaine T, Drapier S, et al
    Functional Role of the Cerebellum in Parkinson Disease: A PET Study.
    Neurology. 2021 Apr 28. pii: WNL.0000000000012036.
    PubMed     Abstract available


  19. NASCIMENTO FA, Cochran RL, Chow DZ, Scott JA, et al
    Teaching NeuroImages: Increasing SPECTations for Ictal SPECT in Epilepsy Surgical Evaluation.
    Neurology. 2021 Apr 26. pii: WNL.0000000000012097.
    PubMed    


  20. VAN DEN AMEELE J, Hong Y, Manavaki R, Kouli A, et al
    [11C]PK11195-PET Brain Imaging of the Mitochondrial Translocator Protein in Mitochondrial Disease.
    Neurology. 2021 Apr 21. pii: WNL.0000000000012033.
    PubMed     Abstract available


  21. ROBERTS G, Durcan Mrcpi R, Donaghy PC, Lawley S, et al
    Accuracy of Cardiac Innervation Scintigraphy for Mild Cognitive Impairment With Lewy Bodies.
    Neurology. 2021 Apr 21. pii: WNL.0000000000012060.
    PubMed     Abstract available


  22. SCHOEMAKER D, Charidimou A, Zanon Zotin MC, Raposo N, et al
    Association of Memory Impairment With Concomitant Tau Pathology in Patients With Cerebral Amyloid Angiopathy.
    Neurology. 2021;96:e1975-e1986.
    PubMed     Abstract available


    March 2021
  23. TOPPALA S, Ekblad LL, Tuisku J, Helin S, et al
    Association of Early beta-Amyloid Accumulation and Neuroinflammation Measured With [(11)C]PBR28 in Elderly Individuals Without Dementia.
    Neurology. 2021;96:e1608-e1619.
    PubMed     Abstract available


  24. POIRION E, Tonietto M, Lejeune FX, Ricigliano VAG, et al
    Structural and Clinical Correlates of a Periventricular Gradient of Neuroinflammation in Multiple Sclerosis.
    Neurology. 2021 Mar 18. pii: WNL.0000000000011700.
    PubMed     Abstract available


  25. GOTTESMAN RF, Hamilton R
    Recruiting Diverse Populations in Clinical Trials: How Do We Overcome Selection Bias?
    Neurology. 2021;96:509-510.
    PubMed    


  26. SEKIGUCHI T, Kanazawa T, Ohkubo T
    Teaching Video NeuroImages: Choreoathetosis Due to Radiation-Induced Brachial Plexopathy.
    Neurology. 2021;96:e1489-e1490.
    PubMed    



  27. Decreased GABA-A Binding on FMZ-PET in Succinic Semialdehyde Dehydrogenase Deficiency.
    Neurology. 2021 Mar 8. pii: WNL.0000000000011754.
    PubMed    


  28. BARKHOF BF, Pressman PS
    Time Is of the Essence: Early Detection of Incipient Alzheimer Pathology.
    Neurology. 2021 Mar 2. pii: WNL.0000000000011739.
    PubMed    


    February 2021
  29. THERRIAULT J, Pascoal TA, Benedet AL, Tissot C, et al
    Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex, APOE epsilon4, and Cognitive Impairment.
    Neurology. 2021;96:e975-e985.
    PubMed     Abstract available


  30. RENTZ DM, Papp KV, Mayblyum DV, Sanchez JS, et al
    Association of Digital Clock Drawing with PET Amyloid and Tau Pathology in Normal Older Adults.
    Neurology. 2021 Feb 15. pii: WNL.0000000000011697.
    PubMed     Abstract available


  31. DETERS K, Napolioni V, Sperling RA, Greicius MD, et al
    Amyloid PET imaging in self-identified non-Hispanic Blacks from the Anti-Amyloid in Asymptomatic Alzheimer's Disease (A4) Study.
    Neurology. 2021 Feb 10. pii: WNL.0000000000011599.
    PubMed     Abstract available


  32. LEE R, Shin JH, Choi H, Kim HJ, et al
    Variability of FP-CIT PET Patterns Associated with Clinical Features of Multiple System Atrophy.
    Neurology. 2021 Feb 3. pii: WNL.0000000000011634.
    PubMed     Abstract available


  33. MALTETE D, Wallon D, Bourilhon J, Lefaucheur R, et al
    Nucleus Basalis of Meynert Stimulation for Lewy Body Dementia: A Phase I Randomized Clinical Trial.
    Neurology. 2021;96:e684-e697.
    PubMed     Abstract available


  34. VAN DER KALL LM, Truong T, Burnham SC, Dore V, et al
    Association of beta-Amyloid Level, Clinical Progression, and Longitudinal Cognitive Change in Normal Older Individuals.
    Neurology. 2021;96:e662-e670.
    PubMed     Abstract available


    January 2021
  35. BLAZHENETS G, Frings L, Ma Y, Sorensen A, et al
    Validation of the Alzheimer Disease Dementia Conversion-Related Pattern as an ATN Biomarker of Neurodegeneration.
    Neurology. 2021 Jan 6. pii: WNL.0000000000011521.
    PubMed     Abstract available


  36. JAGUST WJ, Landau SM
    Temporal Dynamics of Beta-amyloid Accumulation in Aging and Alzheimer's Disease.
    Neurology. 2021 Jan 6. pii: WNL.0000000000011524.
    PubMed     Abstract available


    December 2020
  37. KNOPMAN DS, Jagust WJ
    Alzheimer Disease Spectrum: Syndrome and Etiology from Clinical and PET Imaging Perspectives.
    Neurology. 2020 Dec 22. pii: WNL.0000000000011415.
    PubMed    


  38. FERREIRA D, Przybelski SA, Lesnick TG, Lemstra AW, et al
    beta-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies.
    Neurology. 2020;95:e3257-e3268.
    PubMed     Abstract available


  39. SHIN JH, Lee JY, Kim YK, Shin SA, et al
    Longitudinal change in dopamine transporter availability in idiopathic REM sleep behavior disorder.
    Neurology. 2020;95:e3081-e3092.
    PubMed     Abstract available


  40. LA JOIE R, Visani AV, Lesman-Segev OH, Baker SL, et al
    Association of APOE4 and clinical variability in Alzheimer disease with the pattern of tau- and amyloid-PET.
    Neurology. 2020 Dec 1. pii: WNL.0000000000011270.
    PubMed     Abstract available


  41. OLIVOT JM
    Beyond mismatch, perfusion imaging predicts infarct growth before revascularization.
    Neurology. 2020 Dec 1. pii: WNL.0000000000011271.
    PubMed    


    November 2020
  42. FARRELL ME, Jiang S, Schultz AP, Properzi MJ, et al
    Defining the lowest threshold for amyloid-PET to predict future cognitive decline and amyloid accumulation.
    Neurology. 2020 Nov 16. pii: WNL.0000000000011214.
    PubMed     Abstract available


  43. ILLAN-GALA I, Lleo A, Karydas A, Staffaroni AM, et al
    Plasma tau and neurofilament light in frontotemporal lobar degeneration and Alzheimer's disease.
    Neurology. 2020 Nov 16. pii: WNL.0000000000011226.
    PubMed     Abstract available


  44. HAN JW, Maillard P, Harvey D, Fletcher E, et al
    Association of vascular brain injury, neurodegeneration, amyloid, and cognitive trajectory.
    Neurology. 2020;95:e2622-e2634.
    PubMed     Abstract available


  45. FOSTER CM, Kennedy KM, Daugherty AM, Rodrigue KM, et al
    Contribution of iron and Abeta to age differences in entorhinal and hippocampal subfield volume.
    Neurology. 2020;95:e2586-e2594.
    PubMed     Abstract available


  46. LIM YY, Baker JE, Bruns L Jr, Mills A, et al
    Association of deficits in short-term learning and Abeta and hippocampal volume in cognitively normal adults.
    Neurology. 2020;95:e2577-e2585.
    PubMed     Abstract available


    October 2020
  47. KERCHNER GA, Filippi M
    Abeta-PET pathology accumulation index: Ready for the clinic?
    Neurology. 2020 Oct 19. pii: WNL.0000000000011060.
    PubMed    


  48. LEUZY A, Lilja J, Buckley CJ, Ossenkoppele R, et al
    Derivation and utility of an Abeta-PET pathology accumulation index to estimate Abeta load.
    Neurology. 2020 Oct 19. pii: WNL.0000000000011031.
    PubMed     Abstract available


  49. MENDEZ-GUERRERO A, Laespada-Garcia MI, Gomez-Grande A, Ruiz-Ortiz M, et al
    Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection.
    Neurology. 2020;95:e2109-e2118.
    PubMed     Abstract available


  50. GERTJE EC, van Westen D, Panizo C, Mattsson-Carlgren N, et al
    Association of enlarged perivascular spaces and measures of small vessel and Alzheimers disease.
    Neurology. 2020 Oct 12. pii: WNL.0000000000011046.
    PubMed    


  51. CATRICALA E, Polito C, Presotto L, Esposito V, et al
    Neural correlates of naming errors across different neurodegenerative diseases: A FDG-PET study.
    Neurology. 2020 Oct 1. pii: WNL.0000000000010967.
    PubMed     Abstract available


    September 2020
  52. WHITWELL JL, Tosakulwong N, Schwarz CC, Senjem ML, et al
    Longitudinal anatomic, functional and molecular characterization of Pick's disease phenotypes.
    Neurology. 2020 Sep 28. pii: WNL.0000000000010948.
    PubMed     Abstract available


  53. SAN LEE J, Lee H, Park S, Choe Y, et al
    Association between APOE epsilon2 and Abeta burden in patients with Alzheimer- and Vascular-Type Cognitive Impairment.
    Neurology. 2020 Sep 14. pii: WNL.0000000000010811.
    PubMed     Abstract available


  54. REIMAND J, Collij L, Scheltens P, Bouwman F, et al
    Association of amyloid-beta CSF/PET discordance and tau load five years later.
    Neurology. 2020 Sep 10. pii: WNL.0000000000010739.
    PubMed     Abstract available


  55. GUZMAN-VELEZ E, Martinez J, Papp K, Baena A, et al
    Associative memory and in vivo brain pathology in asymptomatic presenilin-1 E280A carriers.
    Neurology. 2020;95:e1312-e1321.
    PubMed     Abstract available


  56. LUO J, Agboola F, Grant E, Masters CL, et al
    Sequence of Alzheimer disease biomarker changes in cognitively normal adults: A cross-sectional study.
    Neurology. 2020 Sep 1. pii: WNL.0000000000010747.
    PubMed     Abstract available


    August 2020
  57. SNITZ BE, Chang Y, Tudorascu DL, Lopez OL, et al
    Predicting resistance to amyloid-beta deposition and cognitive resilience in the oldest-old.
    Neurology. 2020;95:e984-e994.
    PubMed     Abstract available


  58. KIM JW, Byun MS, Lee JH, Yi D, et al
    Serum albumin and beta-amyloid deposition in the human brain.
    Neurology. 2020;95:e815-e826.
    PubMed     Abstract available


  59. WANG L, Cheng W, Rolls E, Dai F, et al
    Association of specific biotypes in patients with Parkinson disease and disease progression.
    Neurology. 2020 Aug 14. pii: WNL.0000000000010498.
    PubMed     Abstract available


  60. VAN DER ZANDE JJ, Gouw AA, van Steenoven I, van de Beek M, et al
    Diagnostic and prognostic value of EEG in prodromal dementia with Lewy bodies.
    Neurology. 2020;95:e662-e670.
    PubMed     Abstract available


  61. GUO T, Shaw LM, Trojanowski JQ, Jagust WJ, et al
    Association of CSF Abeta, amyloid PET and cognition in cognitively unimpaired elderly adults.
    Neurology. 2020 Aug 5. pii: WNL.0000000000010596.
    PubMed     Abstract available


  62. VANHAUTE H, Ceccarini J, Michiels L, Koole M, et al
    In vivo synaptic density loss is related to tau deposition in amnestic mild cognitive impairment.
    Neurology. 2020;95:e545-e553.
    PubMed     Abstract available


  63. CHAHINE LM, Beach TG, Brumm MC, Adler CH, et al
    In vivo distribution of alpha-synuclein in multiple tissues and biofluids in Parkinson disease.
    Neurology. 2020 Aug 3. pii: WNL.0000000000010404.
    PubMed     Abstract available


    July 2020
  64. VAN HARTEN AC, Wiste HJ, Weigand SD, Mielke MM, et al
    CSF biomarkers in Olmsted County: Evidence of 2 subclasses and associations with demographics.
    Neurology. 2020;95:e256-e267.
    PubMed     Abstract available


  65. COLLIJ LE, Heeman F, Salvado G, Ingala S, et al
    Multi-tracer model for staging cortical amyloid deposition using PET imaging.
    Neurology. 2020 Jul 16. pii: WNL.0000000000010256.
    PubMed     Abstract available


  66. LIU J, Peedicail JS, Gaxiola-Valdez I, Li E, et al
    Postictal brainstem hypoperfusion and risk factors for sudden unexpected death in epilepsy.
    Neurology. 2020 Jul 16. pii: WNL.0000000000010360.
    PubMed     Abstract available


  67. THALER AI, Kim BD, Fara MG
    Teaching NeuroImages: MR Perfusion and Diffusion Findings in Hemiplegic Migraine.
    Neurology. 2020 Jul 9. pii: WNL.0000000000010249.
    PubMed    


  68. KHEDER A, Thome U, Aung T, Krishnan B, et al
    Investigation of Networks Underlying Hyperkinetic Seizures utilizing Ictal SPECT.
    Neurology. 2020 Jul 7. pii: WNL.0000000000009975.
    PubMed     Abstract available


  69. CHUNG SJ, Lee HS, Yoo HS, Lee YH, et al
    Patterns of striatal dopamine depletion in early Parkinson disease: Prognostic relevance.
    Neurology. 2020 Jul 2. pii: WNL.0000000000009878.
    PubMed     Abstract available


    June 2020
  70. BEJANIN A, Tammewar G, Marx G, Cobigo Y, et al
    Longitudinal structural and metabolic changes in frontotemporal dementia.
    Neurology. 2020 Jun 26. pii: WNL.0000000000009760.
    PubMed     Abstract available


  71. RAHMAN A, Schelbaum E, Hoffman K, Diaz I, et al
    Sex-driven modifiers of Alzheimer risk: A multimodality brain imaging study.
    Neurology. 2020 Jun 24. pii: WNL.0000000000009781.
    PubMed     Abstract available


  72. LEE Y, Ko J, Choi YE, Oh JS, et al
    Areas of white matter hyperintensities and motor symptoms of Parkinson disease.
    Neurology. 2020 Jun 23. pii: WNL.0000000000009890.
    PubMed     Abstract available


  73. BUCIUC M, Botha H, Murray ME, Schwarz CG, et al
    Utility of FDG-PET in diagnosis of Alzheimer-related TDP-43 proteinopathy.
    Neurology. 2020 Jun 9. pii: WNL.0000000000009722.
    PubMed     Abstract available


    May 2020
  74. MATTSSON-CARLGREN N, Leuzy A, Janelidze S, Palmqvist S, et al
    The implications of different approaches to define AT(N) in Alzheimer disease.
    Neurology. 2020 May 12. pii: WNL.0000000000009485.
    PubMed     Abstract available


  75. JACOBS HIL, Augustinack JC, Schultz AP, Hanseeuw BJ, et al
    The presubiculum links incipient amyloid and tau pathology to memory function in older persons.
    Neurology. 2020;94:e1916-e1928.
    PubMed     Abstract available


    April 2020
  76. ARUN T, Pattison L, Palace J
    Distinguishing neurosarcoidosis from multiple sclerosis based on CSF analysis: A retrospective cohort study.
    Neurology. 2020 Apr 30. pii: WNL.0000000000009491.
    PubMed     Abstract available


  77. VILAPLANA E, Rodriguez-Vieitez E, Ferreira D, Montal V, et al
    Cortical microstructural correlates of astrocytosis in autosomal dominant Alzheimer disease.
    Neurology. 2020 Apr 14. pii: WNL.0000000000009405.
    PubMed     Abstract available


  78. PARK DC, Abner EL
    Amyloid deposits in the banks (of the superior temporal sulcus) yield a high return about memory futures.
    Neurology. 2020;94:603-604.
    PubMed    


    March 2020
  79. YOO HS, Lee S, Chung SJ, Lee YH, et al
    Clinical and striatal dopamine transporter predictors of beta-amyloid in dementia with Lewy bodies.
    Neurology. 2020;94:e1344-e1352.
    PubMed     Abstract available


  80. BREMOVA-ERTL T, Sztatecsny C, Brendel M, Moser M, et al
    Clinical, ocular motor, and imaging profile of Niemann-Pick type C heterozygosity.
    Neurology. 2020 Mar 31. pii: WNL.0000000000009290.
    PubMed     Abstract available


  81. CARVALHO DZ, St Louis EK, Schwarz CG, Lowe VJ, et al
    Witnessed apneas are associated with elevated tau-PET levels in cognitively unimpaired elderly.
    Neurology. 2020 Mar 26. pii: WNL.0000000000009315.
    PubMed     Abstract available


  82. WALTERFANG M, Di Biase MA, Cropley VL, Scott AM, et al
    Imaging of neuroinflammation in adult Niemann-Pick type C disease: A cross-sectional study.
    Neurology. 2020 Mar 24. pii: WNL.0000000000009287.
    PubMed     Abstract available


    February 2020
  83. SCHOBERL F, Pradhan C, Irving S, Buerger K, et al
    Real-space navigation testing differentiates between amyloid-positive and -negative aMCI.
    Neurology. 2020;94:e861-e873.
    PubMed     Abstract available


  84. CARLISLE TC, Galetta KM, McGinnis SM, Bockow Kaplan T, et al
    Clinical Reasoning: A 58-year-old woman presents with progressive memory deficits, odd behavior, and falls.
    Neurology. 2020;94:e557-e561.
    PubMed    


    January 2020
  85. MARTERSTECK A, Sridhar J, Rader B, Coventry C, et al
    Differential neurocognitive network perturbation in amnestic and aphasic Alzheimer disease.
    Neurology. 2020 Jan 22. pii: WNL.0000000000008960.
    PubMed     Abstract available


    December 2019
  86. CAMPBELL MC, Jackson JJ, Koller JM, Snyder AZ, et al
    Proteinopathy and longitudinal changes in functional connectivity networks in Parkinson disease.
    Neurology. 2019 Dec 18. pii: WNL.0000000000008677.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: